11.11. Analysis.
Comparison 11: Minimally antistaphylococcal cephalosporins C3 (3rd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes, Outcome 11: Maternal skin rash
Comparison 11: Minimally antistaphylococcal cephalosporins C3 (3rd generation) vs broad spectrum penicillins plus betalactamase inhibitors P2+ ‐ all outcomes, Outcome 11: Maternal skin rash